{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:01:05Z","timestamp":1788307265583,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T00:00:00Z","timestamp":1744502400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T00:00:00Z","timestamp":1744502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-90787-6","type":"journal-article","created":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T13:18:32Z","timestamp":1744550312000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Genome-wide association study of common side effects following COVID-19 booster vaccination in a cohort of corporate employees in Japan"],"prefix":"10.1038","volume":"15","author":[{"given":"Yosuke","family":"Omae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seik-Soon","family":"Khor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihoko","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taihei","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiko","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Ebisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko S.","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Mizoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsushi","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,13]]},"reference":[{"key":"90787_CR1","unstructured":"COVID-19 epidemiological update\u201416 February 2024. World Health Organization (WHO). https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20240216_covid-19_epi_update_164.pdf"},{"key":"90787_CR2","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1056\/NEJMoa2110345","volume":"385","author":"SJ Thomas","year":"2021","unstructured":"Thomas, S. J. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months. N. Engl. J. Med. 385, 1761\u20131773. https:\/\/doi.org\/10.1056\/NEJMoa2110345 (2021).","journal-title":"N. Engl. J. Med."},{"key":"90787_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1126\/science.adh2712","volume":"382","author":"F Krammer","year":"2023","unstructured":"Krammer, F. & Ellebedy, A. H. Variant-adapted COVID-19 booster vaccines. Science 382, 157\u2013159. https:\/\/doi.org\/10.1126\/science.adh2712 (2023).","journal-title":"Science"},{"key":"90787_CR4","doi-asserted-by":"publisher","first-page":"366","DOI":"10.17305\/bjbms.2021.7082","volume":"22","author":"H Meng","year":"2022","unstructured":"Meng, H., Mao, J. & Ye, Q. Strategies and safety considerations of booster vaccination in COVID-19. Bosn. J. Basic Med. Sci. 22, 366\u2013373. https:\/\/doi.org\/10.17305\/bjbms.2021.7082 (2022).","journal-title":"Bosn J. Basic. Med. Sci."},{"key":"90787_CR5","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/S0140-6736(22)00044-7","volume":"399","author":"DF Nixon","year":"2022","unstructured":"Nixon, D. F., Schwartz, R. E. & Ndhlovu, L. C. Booster vaccines for COVID-19 vaccine breakthrough cases? Lancet 399, 1224. https:\/\/doi.org\/10.1016\/S0140-6736(22)00044-7 (2022).","journal-title":"Lancet"},{"key":"90787_CR6","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1080\/14760584.2022.2093722","volume":"21","author":"T Naito","year":"2022","unstructured":"Naito, T. et al. Reactogenicity and immunogenicity of BNT162b2 or mRNA-1273 COVID-19 booster vaccinations after two doses of BNT162b2 among healthcare workers in Japan: a prospective observational study. Expert Rev. Vaccines 21, 1319\u20131329. https:\/\/doi.org\/10.1080\/14760584.2022.2093722 (2022).","journal-title":"Expert Rev. Vaccines"},{"key":"90787_CR7","unstructured":"Interim report after the third dose. of mRNA vaccination for primary mRNA vaccine recipients. Ministry of Health, Labour and Welfare Web site. https:\/\/warp.da.ndl.go.jp\/info:ndljp\/pid\/12499217\/www.mhlw.go.jp\/content\/10601000\/001011553.pdf"},{"key":"90787_CR8","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.15585\/mmwr.mm7039e4","volume":"70","author":"AM Hause","year":"2021","unstructured":"Hause, A. M. et al. Safety monitoring of an additional dose of COVID-19 Vaccine - United States, August 12-September 19, 2021. MMWR Morb. Mortal. Wkly.  Rep. 70, 1379\u20131384. https:\/\/doi.org\/10.15585\/mmwr.mm7039e4 (2021).","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"90787_CR9","doi-asserted-by":"publisher","first-page":"6821","DOI":"10.2147\/ijgm.S376316","volume":"15","author":"NA El-Shitany","year":"2022","unstructured":"El-Shitany, N. A. et al. The adverse reactions of Pfizer BioNTech COVID-19 vaccine booster dose are mild and similar to the second dose responses: A retrospective Cross-Sectional study. Int. J. Gen. Med. 15, 6821\u20136836. https:\/\/doi.org\/10.2147\/ijgm.S376316 (2022).","journal-title":"Int. J. Gen. Med."},{"key":"90787_CR10","doi-asserted-by":"publisher","first-page":"4785","DOI":"10.1038\/s41598-024-54886-0","volume":"14","author":"SA Amer","year":"2024","unstructured":"Amer, S. A. et al. Exploring the reported adverse effects of COVID-19 vaccines among vaccinated Arab populations: a multi-national survey study. Sci. Rep. 14, 4785. https:\/\/doi.org\/10.1038\/s41598-024-54886-0 (2024).","journal-title":"Sci. Rep."},{"key":"90787_CR11","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1473-3099(21)00224-3","volume":"21","author":"C Menni","year":"2021","unstructured":"Menni, C. et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID symptom study app in the UK: a prospective observational study. Lancet Infect. Dis. 21, 939\u2013949. https:\/\/doi.org\/10.1016\/S1473-3099(21)00224-3 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"90787_CR12","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 384, 403\u2013416. https:\/\/doi.org\/10.1056\/NEJMoa2035389 (2021).","journal-title":"N Engl. J. Med."},{"key":"90787_CR13","doi-asserted-by":"publisher","first-page":"20820","DOI":"10.1038\/s41598-023-47632-5","volume":"13","author":"S Nogawa","year":"2023","unstructured":"Nogawa, S. et al. A web-based genome-wide association study reveals the susceptibility loci of common adverse events following COVID-19 vaccination in the Japanese population. Sci. Rep. 13, 20820. https:\/\/doi.org\/10.1038\/s41598-023-47632-5 (2023).","journal-title":"Sci. Rep."},{"key":"90787_CR14","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1056\/NEJMoa2116414","volume":"386","author":"RL Atmar","year":"2022","unstructured":"Atmar, R. L. et al. Homologous and heterologous Covid-19 booster vaccinations. N. Engl. J. Med. 386, 1046\u20131057. https:\/\/doi.org\/10.1056\/NEJMoa2116414 (2022).","journal-title":"N Engl. J. Med."},{"key":"90787_CR15","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/tan.15157","volume":"102","author":"C Magri","year":"2023","unstructured":"Magri, C. et al. Genome-wide association studies of response and side effects to the BNT162b2 vaccine in Italian healthcare workers: increased antibody levels and side effects in carriers of the HLA-A*03:01 allele. HLA 102, 707\u2013719. https:\/\/doi.org\/10.1111\/tan.15157 (2023).","journal-title":"HLA"},{"key":"90787_CR16","doi-asserted-by":"publisher","first-page":"100084","DOI":"10.1016\/j.xhgg.2021.100084","volume":"3","author":"A Bolze","year":"2022","unstructured":"Bolze, A. et al. HLA-A\u221703:01 is associated with increased risk of fever, chills, and stronger side effects from Pfizer-BioNTech COVID-19 vaccination. HGG Adv. 3, 100084. https:\/\/doi.org\/10.1016\/j.xhgg.2021.100084 (2022).","journal-title":"HGG Adv."},{"key":"90787_CR17","doi-asserted-by":"publisher","unstructured":"Khor, S. S. et al. An association study of HLA with the kinetics of SARS-CoV-2 Spike specific IgG antibody responses to BNT162b2 mRNA vaccine. Vaccines (Basel) 10 https:\/\/doi.org\/10.3390\/vaccines10040563 (2022).","DOI":"10.3390\/vaccines10040563"},{"key":"90787_CR18","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing (2023)."},{"key":"90787_CR19","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/jb\/mvab060","volume":"170","author":"M Sakurai-Yageta","year":"2021","unstructured":"Sakurai-Yageta, M. et al. Japonica array NEO with increased genome-wide coverage and abundant disease risk SNPs. J. Biochem. 170, 399\u2013410. https:\/\/doi.org\/10.1093\/jb\/mvab060 (2021).","journal-title":"J. Biochem."},{"key":"90787_CR20","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559\u2013575. https:\/\/doi.org\/10.1086\/519795 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"90787_CR21","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.ajhg.2018.07.015","volume":"103","author":"BL Browning","year":"2018","unstructured":"Browning, B. L., Zhou, Y. & Browning, S. R. A One-Penny imputed genome from Next-Generation reference panels. Am. J. Hum. Genet. 103, 338\u2013348. https:\/\/doi.org\/10.1016\/j.ajhg.2018.07.015 (2018).","journal-title":"Am. J. Hum. Genet."},{"key":"90787_CR22","doi-asserted-by":"publisher","unstructured":"Kawai, Y. et al. Mapping of susceptible variants for cold medicine-related Stevens-Johnson syndrome by whole-genome resequencing. NPJ Genomic Med. 6. https:\/\/doi.org\/10.1038\/s41525-021-00171-2 (2021).","DOI":"10.1038\/s41525-021-00171-2"},{"key":"90787_CR23","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1016\/j.cell.2022.08.004","volume":"185","author":"M Byrska-Bishop","year":"2022","unstructured":"Byrska-Bishop, M. et al. High-coverage whole-genome sequencing of the expanded 1000 genomes project cohort including 602 trios. Cell 185, 3426\u20133440.e3419. https:\/\/doi.org\/10.1016\/j.cell.2022.08.004 (2022).","journal-title":"Cell"},{"key":"90787_CR24","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1038\/s41467-017-01261-5","volume":"8","author":"K Watanabe","year":"2017","unstructured":"Watanabe, K., Taskesen, E., van Bochoven, A. & Posthuma, D. Functional mapping and annotation of genetic associations with FUMA. Nat. Commun. 8, 1826. https:\/\/doi.org\/10.1038\/s41467-017-01261-5 (2017).","journal-title":"Nat. Commun."},{"key":"90787_CR25","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51, D638\u2013d646. https:\/\/doi.org\/10.1093\/nar\/gkac1000 (2023).","journal-title":"Nucleic Acids Res."},{"key":"90787_CR26","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41591-022-02078-6","volume":"29","author":"AJ Mentzer","year":"2023","unstructured":"Mentzer, A. J. et al. Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection. Nat. Med. 29, 147\u2013157. https:\/\/doi.org\/10.1038\/s41591-022-02078-6 (2023).","journal-title":"Nat. Med."},{"key":"90787_CR27","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ajhg.2023.12.005","volume":"111","author":"S Bian","year":"2024","unstructured":"Bian, S. et al. Genetic determinants of IgG antibody response to COVID-19 vaccination. Am. J. Hum. Genet. 111, 181\u2013199. https:\/\/doi.org\/10.1016\/j.ajhg.2023.12.005 (2024).","journal-title":"Am. J. Hum. Genet."},{"key":"90787_CR28","doi-asserted-by":"publisher","unstructured":"Otani, J., Ohta, R. & Sano, C. Association between Immunoglobulin G levels and adverse effects following vaccination with the BNT162b2 vaccine among Japanese healthcare workers. Vaccines (Basel). https:\/\/doi.org\/10.3390\/vaccines9101149 (2021).","DOI":"10.3390\/vaccines9101149"},{"key":"90787_CR29","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1056\/nejm199704103361506","volume":"336","author":"PJ Barnes","year":"1997","unstructured":"Barnes, P. J. & Karin, M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336, 1066\u20131071. https:\/\/doi.org\/10.1056\/nejm199704103361506 (1997).","journal-title":"N Engl. J. Med."},{"key":"90787_CR30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nri2691","volume":"10","author":"JE Sims","year":"2010","unstructured":"Sims, J. E. & Smith, D. E. The IL-1 family: regulators of immunity. Nat. Rev. Immunol. 10, 89\u2013102. https:\/\/doi.org\/10.1038\/nri2691 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"90787_CR31","doi-asserted-by":"publisher","unstructured":"Fattori, V.et al. IL-33 enhances macrophage release of IL-1\u03b2 and promotes pain and inflammation in gouty arthritis. Inflamma. Res. 69, 1271\u20131282. https:\/\/doi.org\/10.1007\/s00011-020-01399-x (2020).","DOI":"10.1007\/s00011-020-01399-x"},{"key":"90787_CR32","doi-asserted-by":"publisher","first-page":"22153","DOI":"10.1002\/jcp.28779","volume":"234","author":"A Hosseini","year":"2019","unstructured":"Hosseini, A. et al. LncRNAs associated with multiple sclerosis expressed in the Th1 cell lineage. J. Cell. Physiol. 234, 22153\u201322162. https:\/\/doi.org\/10.1002\/jcp.28779 (2019).","journal-title":"J. Cell. Physiol."},{"key":"90787_CR33","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.cell.2011.06.034","volume":"146","author":"TR Peterson","year":"2011","unstructured":"Peterson, T. R. et al. mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. Cell 146, 408\u2013420. https:\/\/doi.org\/10.1016\/j.cell.2011.06.034 (2011).","journal-title":"Cell"},{"key":"90787_CR34","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/j.bbalip.2019.06.003","volume":"1864","author":"MA Balboa","year":"2019","unstructured":"Balboa, M. A., de Pablo, N., Meana, C. & Balsinde, J. The role of lipins in innate immunity and inflammation. Biochim. Biophys. Acta Mol. Cell. Biol.  Lipids. 1864, 1328\u20131337. https:\/\/doi.org\/10.1016\/j.bbalip.2019.06.003 (2019).","journal-title":"Biochim. Biophys. Acta Mol. Cell. Biology Lipids"},{"key":"90787_CR35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s10549-005-1483-4","volume":"92","author":"JM Rae","year":"2005","unstructured":"Rae, J. M. et al. GREB 1 is a critical regulator of hormone dependent breast cancer growth. Breast Cancer Res. Treat. 92, 141\u2013149. https:\/\/doi.org\/10.1007\/s10549-005-1483-4 (2005).","journal-title":"Breast Cancer Res. Treat."},{"key":"90787_CR36","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s00223-008-9168-8","volume":"83","author":"K Henriksen","year":"2008","unstructured":"Henriksen, K. et al. Ion transporters involved in acidification of the resorption lacuna in osteoclasts. Calcif. Tissue Int. 83, 230\u2013242. https:\/\/doi.org\/10.1007\/s00223-008-9168-8 (2008).","journal-title":"Calcif. Tissue Int."},{"key":"90787_CR37","doi-asserted-by":"publisher","unstructured":"Rioux, G. et al. Gene profiling of a 3D psoriatic skin model enriched in T cells: downregulation of PTPRM promotes keratinocyte proliferation through excessive ERK1\/2 signaling. Cells. https:\/\/doi.org\/10.3390\/cells11182904 (2022).","DOI":"10.3390\/cells11182904"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90787-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90787-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90787-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T13:18:35Z","timestamp":1744550315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90787-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,13]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["90787"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-90787-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,13]]},"assertion":[{"value":"30 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12728"}}